Galapagos N.V.
Galapagos N.V. (GLPG) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · GLPG · as of Jun 8, 2026
Key Statistics
Explore Galapagos N.V. Data
glpg stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 24 · Buy rate: 37.5%
The GLPG analyst consensus is Hold, based on ratings from 24 Wall Street analysts over the past 3 months. The average 12-month price target is $33.00, representing +17.94% upside from the current price of $27.98.
Competitors & Peers
glpg competitorsGLPG
COGT
DNLI
ETNB
GPCR
IBRXStock Performance
Full HistoryAbout Galapagos N.V.
Galapagos N.V. Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filg…
what is galapagos n.v. · glpg stock overview · galapagos n.v. company profile · who is galapagos n.v. ceo · glpg NASDAQ · galapagos n.v. headquarters · galapagos n.v. business segments
About Stock Overview & Key Data
Galapagos N.V. (GLPG) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Feb 27, 2012. As of the latest trading session, GLPG stock price is $27.98, with a market capitalization of $1.8B. The stock has returned -0.39% over the past 12 months and -14.43% year-to-date.
According to 24 Wall Street analysts, the consensus rating for Galapagos N.V. stock is Hold, with an average 12-month price target of $33.00. In fiscal year 2025, Galapagos N.V. reported revenue of $1.1B and net income of $320.9M. For detailed data — including Galapagos N.V. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Galapagos N.V. (GLPG) stock price is $27.98. The stock is traded on NASDAQ under the ticker symbol GLPG. The 52-week range is $24.74 – $37.78.